Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
28.71
-0.16 (-0.55%)
At close: May 01, 2025, 3:59 PM
28.96
0.87%
Pre-market: May 02, 2025, 08:05 AM EDT

Viking Therapeutics Revenue

Viking Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Viking Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
45
Market Cap
3.22B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.